LAUSR

Allosterically targeting EGFR drug-resistance gatekeeper mutations.

Sign Up to like & get
recommendations!
0 Published in 2017 at "Journal of thoracic disease"

DOI: 10.21037/jtd.2017.06.43

Abstract: Lung cancer is by far the leading cause of cancer-related death with nearly 1.7 million deaths worldwide in 2016. The most common type of lung cancer is non-small cell lung cancer (NSCLC) accounting for 80%… read more here.

Keywords: lung cancer; allosterically targeting; targeting egfr; cancer ... See more keywords